BR9814433A - "beta-lipotropina e usos da mesma" - Google Patents

"beta-lipotropina e usos da mesma"

Info

Publication number
BR9814433A
BR9814433A BR9814433-2A BR9814433A BR9814433A BR 9814433 A BR9814433 A BR 9814433A BR 9814433 A BR9814433 A BR 9814433A BR 9814433 A BR9814433 A BR 9814433A
Authority
BR
Brazil
Prior art keywords
beta
lipotropin
fragments
lipotropine
analogs
Prior art date
Application number
BR9814433-2A
Other languages
English (en)
Inventor
Gerald Wayne Becker
Jon Paul Butler
John Edward Hale
William Francis Heath Jr
Mark Louis Heiman
Brigitte Elisabeth Schoner
Alexander David Varshavsky
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9814433A publication Critical patent/BR9814433A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/67—Lipotropins, e.g. beta, gamma lipotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Patente de Invenção: <B>"BETA-LIPOTROPINA E USOS DA MESMA"<D>. A invenção proporciona novos ácidos nucléicos, vetores, células hospedeiras transformadas, análogos fragmentos funcionais e proteínas de fusão relacionados à beta-lipotropina. Também proporcionadas são composições farmacêuticas compreendendo beta-lipotropina e/ou fragmentos e/ou análogos da mesma e métodos para o tratamento de diabetes e complicações associadas com a mesma através de administração de uma quantidade efetiva de beta-lipotropina.
BR9814433-2A 1997-12-23 1998-12-21 "beta-lipotropina e usos da mesma" BR9814433A (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US6865997P 1997-12-23 1997-12-23
US7985798P 1998-03-30 1998-03-30
US8632198P 1998-05-21 1998-05-21
US9138598P 1998-07-01 1998-07-01
US9540598P 1998-08-05 1998-08-05
US10397698P 1998-10-13 1998-10-13
PCT/US1998/027238 WO1999032142A1 (en) 1997-12-23 1998-12-21 Beta-lipotropin and uses thereof

Publications (1)

Publication Number Publication Date
BR9814433A true BR9814433A (pt) 2000-10-10

Family

ID=27557000

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814433-2A BR9814433A (pt) 1997-12-23 1998-12-21 "beta-lipotropina e usos da mesma"

Country Status (18)

Country Link
US (2) US6323178B1 (pt)
EP (1) EP0926239A3 (pt)
JP (1) JP2001526061A (pt)
KR (1) KR20010024805A (pt)
CN (1) CN1284882A (pt)
AR (1) AR018532A1 (pt)
AU (1) AU1938599A (pt)
BR (1) BR9814433A (pt)
CA (1) CA2315888A1 (pt)
CO (1) CO4930304A1 (pt)
EA (1) EA200000709A1 (pt)
HR (1) HRP20000426A2 (pt)
HU (1) HUP0100132A2 (pt)
IL (1) IL136514A0 (pt)
PE (1) PE20000062A1 (pt)
PL (1) PL341293A1 (pt)
TR (1) TR200002611T2 (pt)
WO (1) WO1999032142A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002232596A1 (en) * 2000-12-13 2002-06-24 Incyte Genomics, Inc. Secreted human proteins
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US8227194B2 (en) * 2005-04-08 2012-07-24 University Of Maryland, Baltimore Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32)
US20090281519A1 (en) * 2008-05-12 2009-11-12 Rao R Harsha Automated system and method for diabetes control
CN119161446B (zh) * 2024-11-22 2025-02-14 杭州诺泰诺和生物医药科技有限公司 胰淀素类似物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US5258496A (en) * 1990-07-10 1993-11-02 Scios Nova Inc. Isolation and purification of lung surfactant protein
EP0723402B1 (en) * 1993-08-30 2010-08-18 Baylor College Of Medicine Senescent cell-derived inhibitors of dna synthesis
US5478852C1 (en) 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5691309A (en) 1995-01-31 1997-11-25 Eli Lilly And Company Anti-obesity proteins

Also Published As

Publication number Publication date
US6323178B1 (en) 2001-11-27
HUP0100132A2 (hu) 2001-05-28
WO1999032142A1 (en) 1999-07-01
EA200000709A1 (ru) 2000-12-25
EP0926239A3 (en) 2002-08-28
HRP20000426A2 (en) 2000-10-31
KR20010024805A (ko) 2001-03-26
CO4930304A1 (es) 2000-06-27
PE20000062A1 (es) 2000-02-08
PL341293A1 (en) 2001-04-09
US20030073621A1 (en) 2003-04-17
EP0926239A2 (en) 1999-06-30
CA2315888A1 (en) 1999-07-01
AR018532A1 (es) 2001-11-28
JP2001526061A (ja) 2001-12-18
TR200002611T2 (tr) 2000-12-21
CN1284882A (zh) 2001-02-21
AU1938599A (en) 1999-07-12
IL136514A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
RU95115239A (ru) Аналог эритропоэтина
BR9814276A (pt) Antìgenos de superfìcie
EP2277889A3 (en) Fusion proteins of albumin and interferon beta
AR008727A1 (es) COMPOSICIONES Y PROTEINAS DE FUSIoN QUE COMPRENDEN UN POLIPEPTIDO QUE COMPRENDE UNA PORCION INMUNOGENICA DE UNA PROTEINA DE PROSTATA O SU VARIANTE, Y USOS DE LAS MISMAS PARA PREPARAR UN MEDICAMENTO
EP2298355A3 (en) Albumin fusion proteins
DE3676670D1 (de) Solubilisierung von proteinen fuer pharmazeutische zusammensetzungen mittels polymerkonjugierung.
BR0207576A (pt) Variante glicosilada de um polipeptìdeo de interferon beta precursor (ifnb), processos de aumentar a glicosilação in vivo de uma molécula de ifnb precursora, de produzir uma molécula de ifnb glicosilada, para preparar uma variante conjugada e de tratar um mamìfero com esclerose múltiplam composição farmacêutica, molécula de ifnb variante, sequência de nucleotìdeo, vetor de expressão, célula hospedeira de glicosilação conjugado, e, uso de um conjugado
WO2003059934A3 (en) Albumin fusion proteins
PT737207E (pt) Inibidores de plasmina humana derivados de dominios kunitz
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
BR0007840A (pt) Proteìnas de fusão her-2/neu
BR9915919A (pt) Proteìnas terapeuticamente ativas em plantas
BRPI0417341A (pt) fator ix glicopeguilado
BR9712518A (pt) Polipeptìdeo, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processo para detectar tuberculose em um paciente, e, kit diagnóstico
HK1001495B (en) Obesity (ob) peptides capable of modulating body weight of animals, allelic variants, analogs and fragments thereof, derivatives, nucleic acid sequences, vectors, hosts and the like related thereto, and pharmaceutical compositions and related uses
BR9809445A (pt) Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico.
BR0007035A (pt) Métodos de controle de pragas de agrótis
WO2003030821A3 (en) Albumin fusion proteins
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR9508467A (pt) Composição de matéria peptídeo de ligação de receptor de somatostatina composição farmacéutica e processo para realizar uma cirurgia guiada por radiosótopos ou um procedimento de radiodiagnóstico ou radioterapéutico e para aliviar uma doença relacionada com somatostetina em um animal
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
BR9803960A (pt) Gene de desidrogenase de d-sorbitol.
AR035077A1 (es) Polipeptidos de neublastina variante, proteinas de fusion, acidos nucleicos, vectores, celulas hospedadoras, metodos para producir dichos polipeptidos, dimeros, conjugados, composiciones farmaceuticas y uso de dichos polipeptidos en la preparacion de medicamentos
BR9814433A (pt) &#34;beta-lipotropina e usos da mesma&#34;
FI972170A7 (fi) Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, n äitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5O, 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.